GB2427471B - Pre-symptomatic markers for diseases associated with transmissable spongiform encephalopaties - Google Patents

Pre-symptomatic markers for diseases associated with transmissable spongiform encephalopaties

Info

Publication number
GB2427471B
GB2427471B GB0619301A GB0619301A GB2427471B GB 2427471 B GB2427471 B GB 2427471B GB 0619301 A GB0619301 A GB 0619301A GB 0619301 A GB0619301 A GB 0619301A GB 2427471 B GB2427471 B GB 2427471B
Authority
GB
United Kingdom
Prior art keywords
diseases associated
symptomatic
markers
transmissable spongiform
encephalopaties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0619301A
Other versions
GB2427471A (en
GB0619301D0 (en
Inventor
Laura Manuelidis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB0619301D0 publication Critical patent/GB0619301D0/en
Publication of GB2427471A publication Critical patent/GB2427471A/en
Application granted granted Critical
Publication of GB2427471B publication Critical patent/GB2427471B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G01N2333/70564—Selectins, e.g. CD62
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB0619301A 2004-03-04 2005-03-04 Pre-symptomatic markers for diseases associated with transmissable spongiform encephalopaties Expired - Fee Related GB2427471B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55063304P 2004-03-04 2004-03-04
US57245704P 2004-05-18 2004-05-18
PCT/US2005/007189 WO2005091969A2 (en) 2004-03-04 2005-03-04 Pre-symptomatic markers for diseases associated with transmissible spongiform encephalopathies

Publications (3)

Publication Number Publication Date
GB0619301D0 GB0619301D0 (en) 2006-11-15
GB2427471A GB2427471A (en) 2006-12-27
GB2427471B true GB2427471B (en) 2009-07-22

Family

ID=35056707

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0619301A Expired - Fee Related GB2427471B (en) 2004-03-04 2005-03-04 Pre-symptomatic markers for diseases associated with transmissable spongiform encephalopaties

Country Status (2)

Country Link
GB (1) GB2427471B (en)
WO (1) WO2005091969A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA020412B1 (en) 2006-09-05 2014-11-28 Видовре Хоспитал Ip-10 based immunological monitoring

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BAKER et al, Unique inflammatory RNA profiles of microglia in Creutzfeld-Jakob disease, PNAS, USA, 2003, 100, 675-679 *
Journal of Neurovirology (Feb 2004); Vol 10, pp 29-40, "Early induction of interferon-responsive...", Baker et al *
Journal of Virology (2002); Vol 76, pp 10905-10913, "Microglia from Creutzfeld-Jacob disease...", Baker et al *
MABBOTT et al, Temporary blocade of the tumour necrosis factor signalling pathway impeded the spread of scrapie to the brain, J. Virology, 2002, 76 *
STARKE et al, Endothelial cell express and release soluble prion protein, 43rd Annual meeting of American Society of Hematology, 2001, 98, 247a-248a *
ZHI YUN LU, New molecular markers of early and progressive CJD brain infection, J. Cell Biochemistry, 2004, 93, 644-652 *

Also Published As

Publication number Publication date
GB2427471A (en) 2006-12-27
WO2005091969A2 (en) 2005-10-06
WO2005091969B1 (en) 2006-05-18
WO2005091969A3 (en) 2006-04-06
WO2005091969A8 (en) 2006-11-09
GB0619301D0 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
HUE054365T2 (en) Boronophthalides for therapeutic use
TWI365078B (en) Hemostat
GB0621452D0 (en) Therapy for liver disease
EP1874206A4 (en) Tissue repair system
EP1773299A4 (en) Tissue matrix system
HK1113990A1 (en) Wheelchair
EP1754485A4 (en) Remedy for neurodegenerative diseases
GB0624200D0 (en) Wheelchairs
GB0610415D0 (en) Tissue repair
GB0504206D0 (en) Combination therapy
EP1806145A4 (en) Remedy for inflammatory diseases
GB0509052D0 (en) Combination therapy
ZA200709627B (en) Combination therapy
GB0507003D0 (en) Therapeutic
GB0518720D0 (en) Therapeutic combination
GB0501655D0 (en) Therapeutic use
GB2427471B (en) Pre-symptomatic markers for diseases associated with transmissable spongiform encephalopaties
PL1927353T3 (en) Remedy for corneal diseases
GB0509917D0 (en) Wheelchairs
PL114821U1 (en) Coffin
GB0517075D0 (en) Modelmaking scalpel
GB0618245D0 (en) Markers for disease
PL115250U1 (en) Coffin
GB0406708D0 (en) Coffin
GB0511259D0 (en) Therapeutic utrasound system

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20200304